Loading...
•
Jun 30, 2024
Baxter Q2 2024 Earnings Report
Baxter's Q2 2024 earnings exceeded expectations, driven by strategic transformation and strong segment performance.
Key Takeaways
Baxter International Inc. reported a 3% increase in worldwide sales from continuing operations, totaling $3.81 billion. U.S. GAAP diluted EPS from continuing operations was ($0.62), while adjusted diluted EPS from continuing operations reached $0.68, both exceeding previous guidance. The company has raised its full-year sales and adjusted diluted EPS guidance.
Second-quarter sales increased by 3% on a reported basis and 4% on a constant currency basis, surpassing previous guidance.
U.S. sales increased by 3% year-over-year, while international sales also increased by 3% on a reported basis.
Adjusted diluted EPS from continuing operations was $0.68, exceeding the company’s previously issued guidance.
Baxter increased its full-year sales growth and adjusted diluted EPS guidance.
Revenue by Geographic Location
Forward Guidance
Baxter expects sales growth of approximately 3% on both a reported and constant currency basis for full-year 2024. The company anticipates adjusted earnings of $2.93 to $3.01 per diluted share. For the third quarter of 2024, sales growth is expected to be 3% to 4% on a reported basis and 4% to 5% on a constant currency basis, with adjusted earnings of $0.77 to $0.79 per diluted share.
Positive Outlook
- Sales growth - U.S. GAAP 3% - 4% (Q3 2024)
- Sales growth - Constant currency 4% - 5% (Q3 2024)
- Sales growth - U.S. GAAP ~ 3% (FY 2024)
- Sales growth - Constant currency ~ 3% (FY 2024)
- Adjusted diluted EPS $0.77 - $0.79 (Q3 2024)
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...